Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B1

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1346-1353

  Jack, Dominic L ^a   Dodds, Alister W ^b   Anwar, Natasha ^c   Ison, Catherine A ^c   Law, Alex ^b   Frosch, Matthias ^d   Turner, Malcolm W ^a   Klein, Nigel J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MRC Immunochemistry Unit   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d Institute of Hygiene and Microbiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; COMPLEMENT; COMPLEMENT COMPONENT C4; LECTIN; MANNOSE BINDING PROTEIN; OPSONIN; SERINE PROTEINASE; SIALIC ACID; SIALIDASE;

ARTICLE; BACTERIAL MEMBRANE; BACTERIUM MUTANT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FLOW CYTOMETRY; LECTIN BINDING; NEISSERIA MENINGITIDIS; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; SIALYLATION;

BACTERIAL PROTEINS; CARRIER PROTEINS; COLLECTINS; COMPLEMENT ACTIVATION; COMPLEMENT C4; HUMANS; LECTINS; LIPOPOLYSACCHARIDES; MUTAGENESIS, INSERTIONAL; NEISSERIA MENINGITIDIS; NEURAMINIDASE; RECEPTORS, MITOGEN; SEROTYPING;

EID: 0031914961     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Holmskov, U., R. Malhotra, R. B. Sim, and J. C. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defence system. Immunol. Today 15:67.
2. Turner, M. W. 1996. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17:532.
3. Epstein, J., Q. Eichbaum, S. Sheriff, and R. A. B. Ezekowitz. 1996. The collectins in innate immunity. Curr. Opin. Immunol. 8:29.
4. Weis, W. I., and K. Drickamer. 1994. Trimeric structure of a C-type mannose-binding protein. Structure 2:1227.
5. Thiel, S., U. Holmskov, L. Hviid, S. B. Laursen, and J. C. Jensenius. 1992. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp. Immunol. 90:31.
6. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451.
7. Ohta, M., M. Okada, I. Yamashina, and T. Kawasaki. 1990. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J. Biol. Chem. 265:1980.
8. Matsushita, M., A. Takahashi, H. Hatsuse, M. Kawakami, and T. Fujita. 1992. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem. Biophys. Res. Commun. 183:645.
9. Matsushita, M., and T. Fujita. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med. 176:1497.
10. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K. B. M. Reid, and J. Jensenius. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506.
11. Sumiya, M., M. Super, P. Tabona, R. J. Levinsky, T. Arai, M. W. Turner, and J. A. Summerfield. 1991. Molecular basis of opsonic defect in immunodeficient children. Lancet 337:1569.
12. Lipscombe, R. J., M. Sumiya, A. V. Hill, Y. L. Lau, R. J. Levinsky, J. A. Summerfield, and M. W. Turner. 1992. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene [published erratum appears in Hum Mol Genet 1993 Mar;2(3):342]. Hum. Mol. Genet. 1:709.
13. Madsen, H. O., P. Garred, J. A. Kurtzhals, L. U. Lamm, L. P. Ryder, S. Thiel, and A. Svejgaard. 1994. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogentics 40:37.
14. Garred, P., H. O. Madsen, J. A. Kurtzhals, L. U. Lamm, S. Thiel, A. S. Hey, and A. Svejgaard. 1992. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur. J. Immunogenet. 19:403.
15. Lipscombe, R. J., D. W. Beatty, M. Ganczakowski, E. A. Goddard, T. Jenkins, Y.-L. Lau, A. B. Spurdle, M. Sumiya, J. A. Summerfield, and M. W. Turner. 1996. Mutations in the human mannan binding lectin gene: frequencies in several population groups. Eur. J. Hum. Genet. 4:13.
16. Summerfield, J. A., M. Sumiya, M. Levin, and M. W. Turner. 1997. Mannose-binding protein gene mutations are associated with childhood infections in a consecutive hospital series. Br. Med. J. 314:1229.
17. Super, M., S. Thiel, J. Lu, R. J. Levinsky, and M. W. Turner. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet ii:1236.
18. Summerfield, J. A., S. Ryder, M. Sumiya, M. Thursz, A. Gorchein, M. A. Monteil, and M. W. Turner 1995:. Mannose-binding protein gene-mutations associated with unusual and severe infections in adults. Lancet 345:886.
19. Haurum, J. S., S. Thiel, I. M. Jones, P. B. Fischer, S. B. Laursen, and J. C. Jensenius. 1993. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 7:1307.
20. Hartshorn, K. L., K. Sastry, M. R. White, E. M. Anders, M. Super, R. A. Ezekowitz, and A. I. Tauber. 1993. Human mannose-binding protein functions as an opsonin for influenza A viruses. J. Clin. Invest. 91:1414.
21. Tabona, P., A. Mellor, and J. A. Summerfield. 1995. Mannose-binding protein is involved in first-line host-defense: evidence from transgenic mice. Immunology 85:153.
22. Cross, C. E., and G. J. Bancroft. 1995. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 63:2604.
23. Schelenz, S., R. Malhotra, R. B. Sim, U. Holmskov, and G. J. Bancroft. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360.
24. Kawasaki, N., T. Kawasaki, and I. Yamashina. 1989. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J. Biochem. 106:483.
25. Kuhlman, M., K. Joiner, and R. A. Ezekowitz. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1733.
26. van Emmerik, L. C., E. J. Kuijper, C. A. Fijen, J. Danken, and S. Thiel. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97:411.
27. Polotsky, V. Y., J. T. Belisle, K. Mikusova, R. A. B. Ezekowitz, and K. A. Joiner. 1997. Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis. 175:1159.
28. Densen, P., J. M. Weiler, J. M. Griffiss, and L. G. Hoffmann. 1987. Familial properdin deficiency and fatal meningococcemia: correction of the bactericidal defect by vaccination. N. Engl. J. Med. 316:922.
29. Fijen, C. A., E. J. Kuijper, A. J. Hannema, A. G. Sjoholm, and J. P. van Putten. 1989. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet ii:585.
30. Lipscombe, R. J., M. Sumiya, J. A. Summerfield, and M. W. Turner. 1995. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85:660.
31. Dodds, A. W. 1993. Small scale preparation of complement components C3 and C4. Methods Enzymol. 2336:46.
32. Hammerschmidt, S., C. Birkholz, U. Zahringer, B. D. Robertson, J. van Putten, O. Ebeling, and M. Frosch. 1994. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol. Microbiol. 11:885.
33. Apicella, M. A., K. M. Bennet, C. A. Hermerath, and D. E. Roberts. 1981. Monoclonal antibody analysis of lipooligosaccharide from Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 34:751.
34. Mandrell, R. E., J. M. Griffiss, and B. A. Macher. 1988. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. J. Exp. Med. 168:107.
35. Mandrell, R. E., A. J. Lesse, J. V. Sugal, M. Shero, J. M. Griffiss, J. A. Cole, N. J. Parsons, H. Smith, S. A. Morse, and M. A. Apicella. 1990. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171:1649.
36. Mandrell, R. E., J. J. Kim, C. M. John, B. W. Gibson, J. V. Sugai, M. A. Apicella, J. M. Griffiss, and R. Yamasaki. 1991. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173:2823.
37. Dodds, A. W., X.-D. Ren, A. C. Willis, and S. K. A. Law. 1996. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379:177.
38. Rowe, P. C., R. H. McLean, R. A. Wood, R. J. Leggiadro, and J. A. Winkelstein. 1989. Association of homozygous C4B deficiency with bacterial meningitis. J. Infect. Dis. 160:448.
39. Bishof, N. A., T. R. Welch, and L. S. Beischel. 1990. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J. Infect. Dis. 162:248.
40. Cates, K. L., P. Densen, J. C. Lockman, and R. P. Levine. 1992. C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria. J. Infect. Dis. 165:942.
41. Nevens, J. R., A. K. Mallia, M. W. Wendt, and P. K. Smith. 1992. Affinity chromatographic purification of immunoglobulin M antibodies utilizing immobilized mannan binding protein. J. Chromatogr. 597:247.
42. Klein, N. J., R. S. Heyderman, and M. Levin. 1993. Management of meningococcal infections. Br. J. Hosp. Med. 50:42.
43. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55: 174.
44. Bitter-Suermann, D., and J. Roth. 1987. Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumour cells. Immunol. Res. 6:225.
45. Jones, D. M., R. Borrow, R. Fox, S. Gray, K. A. Cartwright, and J. T. Poolman. 1992. The lipooligosaccharide immunotype as a virulence factor determinant in Neisseria meningitidis. Microb. Pathogen. 13:219.
46. Vogel, U., S. Hammerschmidt, and M. Frosch. 1996. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for the virulence of meningococci in the infant rat. Med. Microbiol. Immunol. 185:81.
47. Klein, N. J., C. A. Ison, M. Peakman, M. Levin, S. Hammerschmidt, M. Frosch, and R. S. Heyderman. 1996. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J. Infect. Dis. 173:172.
48. Patrick, C. C., G. T. Furuta, M. E. Edwards, M. Estabrook, M. S. Blake, and C. J. Baker. 1993. Variation in phenotypic expression of the Opa outer membrane protein and lipooligosaccharide of Neisseria meningitidis serogroup C causing periorbital cellulitis and bacteremia. Clin. Infect. Dis. 16:523.
49. Waage, A., A. Halstensen, and T. Epsevik. 1987. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i:355.
50. Brandtzaeg, P., T. E. Mollnes, and P. Kierulf. 1989. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160:58.
51. Tenner, A. J., S. L. Robinson, and R. A. B. Ezekowitz. 1995. Mannose-binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity 3:485.
52. p, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119.
53. Soell, M., E. Lett, F. Holveck, M. Scholler, D. Wachsmann, and J. P. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. J. Immunol. 154:851.
54. Garred, P., T. E. Michaelsen, G. Bjune, S. Thiel, and A. Svejgaard. 1993. A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand. J. Immunol. 37:468.
55. Schneider, H., J. McLeod Griffiss, J. W. Boslego, P. J. Hitchcock, K. M. Zahos, and M. A. Apicella. 1991. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:1601.
56. Vogel, U., A. Weinberger, R. Frank. A. Müller, M. Frosch, and J. P. Atkinson. 1997. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect. Immun. 65:4022.